Systemic lupus erythematosus (SLE) is an autoimmune disease mediated by autoantibodies and preferentially affecting women of childbearing age. Because the offspring of mothers with SLE show a high frequency of learning disorders 1-5 , we hypothesized that maternally transferred autoantibodies that bind DNA and the N-methyl-D-aspartate receptor (NMDAR) 6-12 could have a pathogenic role during fetal brain development. Here we describe a maternal SLE mouse model wherein pregnant dams harbored DNA-specific, NMDAR-specific autoantibodies throughout gestation. High titers of these autoantibodies in maternal circulation led to histological abnormalities in fetal brain and subsequent cognitive impairments in adult offspring. These data support a paradigm in which in utero exposure to neurotoxic autoantibodies causes abnormal brain development with long-term consequences. This paradigm may apply to multiple congenital neuropsychiatric disorders.
Systemic lupus erythematosus (SLE) is an autoimmune disease mediated by autoantibodies and preferentially affecting women of childbearing age. Because the offspring of mothers with SLE show a high frequency of learning disorders [1] [2] [3] [4] [5] , we hypothesized that maternally transferred autoantibodies that bind DNA and the N-methyl-D-aspartate receptor (NMDAR) [6] [7] [8] [9] [10] [11] [12] could have a pathogenic role during fetal brain development. Here we describe a maternal SLE mouse model wherein pregnant dams harbored DNA-specific, NMDAR-specific autoantibodies throughout gestation. High titers of these autoantibodies in maternal circulation led to histological abnormalities in fetal brain and subsequent cognitive impairments in adult offspring. These data support a paradigm in which in utero exposure to neurotoxic autoantibodies causes abnormal brain development with long-term consequences. This paradigm may apply to multiple congenital neuropsychiatric disorders.
Children born to mothers with SLE show a high incidence of learning disorders compared to children born to healthy mothers [1] [2] [3] [4] [5] . The mechanisms for these learning disorders remain unknown, but prematurity, low birth weight, maternal disease activity and medications during pregnancy have not emerged as causative factors. Remarkably, a single study showed that children born from SLE fathers did not show learning disorders 1 . This led us to ask whether maternally derived factors, particularly antibodies, might alter fetal brain development in utero, resulting in long-term cognitive changes in the offspring [1] [2] [3] [4] [5] .
Previous work has identified SLE autoantibodies that bind DNA and cross-react with native NMDAR 6, 7 . Indeed, 30-60% of individuals with SLE show these cross-reactive autoantibodies, which are found in serum, cerebrospinal fluid and brain parenchyma [8] [9] [10] [11] [12] [13] . Moreover, titers of these autoantibodies in the cerebrospinal fluid correlate significantly with manifestations of neuropsychiatric SLE 8, 14 . Our studies in mouse models of neuropsychiatric SLE show that NMDAR-specific autoantibodies mediate cognitive and behavioral abnormalities only after breaches in the blood-brain barrier (BBB) 15, 16 . The nature of the brain injury depends on the regional specificity of the compromise of the BBB. When the BBB is disrupted by systemic administration of lipopolysaccharide, mimicking infection, neuronal injury occurs within the hippocampus and is associated with memory impairment 15 . When epinephrine is used to breach the BBB, neuronal death in the amygdala leads to abnormal fear responses 16 .
Intrauterine and perinatal exposure to maternal immunoglobulin (IgG) is a physiological event. During pregnancy, IgG is transported from mother to fetus across the placenta 17 . Appreciable rates of IgG transfer begin by the end of the first trimester. At term, the IgG concentration in the fetal circulation can exceed that in the maternal circulation. Postnatally, maternally acquired antibodies are essential in the newborn's immunity. They can, however, mediate tissue injury. For example, neonatal lupus, characterized by cutaneous lesions and congenital heart block, is mediated by autoantibodies specific for Ro, a ribonucleoprotein 18 .
We exploited a mouse model in which dams harbor NMDARspecific autoantibodies throughout gestation. We examined how in utero autoantibody exposure affected fetal brain development and behavioral outcome in adult offspring ( Supplementary Fig. 1 online) . The D/EWD/EYS/G peptide is a mimetope of DNA; this consensus sequence is present within the NR2A and NR2B subunits of the NMDAR. Mice immunized with DWEYS pentapeptide included within a decapeptide sequence that is octamerized on a polylysine backbone, termed MP mice, randomly developed either high or low titers of DNA-specific, NMDAR-specific autoantibodies, as previously described 19 , whereas female mice that were immunized with polylysine backbone alone, termed MC mice, did not ( Fig. 1a) . Three weeks later, MP and MC females were impregnated. We collected serum from MP and MC mice just before the timed pregnancy and at the time of harvesting embryonic day 15 (E15) fetal brains or just before the timed pregnancy and at postnatal day 0 (P0). The presence of NMDAR-specific autoantibodies in the maternal circulation was assessed by peptide ELISA. Stable titers of NMDAR-specific autoantibodies were present throughout pregnancy in MP dams ( Fig. 1a) . Given the intrinsic variability in autoantibody production across the various mice, we were able to segregate MP dams into high autoantibody titer (MPH) and low autoantibody titer (MPL) groups. There was no appreciable reactivity to DNA (data not shown) or NMDAR in MC dams ( Fig. 1a) .
To confirm that the maternal antibodies were able to enter the fetal brain, we conjugated R4A, a monoclonal NMDAR-specific autoantibody, to europium. On E14, we gave europium-labeled R4A to nonimmunized pregnant dams, and, 24 h later, we detected europium-labeled R4A in the fetal neocortex outside of blood vessels ( Supplementary Fig. 2a online), demonstrating transport of NMDAR-specific autoantibodies through fetal circulation and binding of the autoantibodies to fetal brain. Autoantibodies were present primarily in the ventricular zone ( Supplementary Fig. 2a ), probably reflecting the transport route into brain. We performed this analysis for each of our monoclonal antibodies ( Supplementary Fig. 2b ) and found 60-70-fold more antibody in fetal brain than maternal brain per milligram of tissue ( Supplementary Fig. 2c ). To show NMDAR antigen in fetal brain, we stained E15 brains directly with R4A or a human monoclonal autoantibody with similar specificity (Supplementary Fig. 2d ). Reactivity was greatest in the neocortex, reflecting NMDAR expression at this stage of brain development.
To determine whether fetal neurons were vulnerable to autoantibody-mediated excitotoxicity, as we had shown for adult neurons 6 , we compared brains from E15 fetuses of MP and MC dams. In utero exposure to maternal NMDAR-specific autoantibodies caused increased neocortical cell death in E15 MP fetuses, as assessed by TUNEL assay (Fig. 1b) . Thus, the maternal autoantibodies were toxic to the developing brain.
We reasoned that a toxic effect of NMDAR-specific autoantibodies might be counterbalanced by increased neurogenesis. Thus, we looked for compensatory cell proliferation in E15 brains by using phosphohistone-3 (PH3) reactivity as a readout. Expression of the M phase cell cycle marker PH3 is widely used for assessing mitotic activity 20 . In MP and MC fetuses, PH3 + cells were appropriately localized near the apical surface of the lateral ventricle ( Fig. 1c) . In MP neocortex, there were more PH3 + cells distant from the germinal zones of the developing brain, suggesting both increased proliferation and perhaps a dysregulated cell cycle progression or abnormal migration of proliferating cells.
Neocortical development is a highly orchestrated process beginning with migration of postmitotic neurons into the cortical plate 21 . After entering the cortical plate, postmitotic neurons organize into cortical lamina 21 . Coronal brain sections were probed for expression of nestin, an intermediate filament protein present in neuronal precursors. DAPI was used to stain cell nuclei. The cortical plate was visualized as a cellular band, rich in DAPI staining and negative for nestin ( Fig. 1d ). On E15, the cortical plate was markedly thinner in MP brains, and the ratio of cortical plate to total cerebral width was markedly reduced ( Fig. 1d-f ), suggesting that proper organization of postmitotic neurons was disrupted by maternal NMDAR-specific autoantibodies. To further control for antibody specificity, we immunized the dams with a scrambled (WSDYEVWLSN) or an alanine-rich (AAAAAVWLSN) sequence. These dams did not show NMDAR-specific or DNA-specific reactivity, and the brains of their fetuses were indistinguishable from MC brains ( Supplementary Fig. 3 online) .
To confirm that NMDAR-specific autoantibodies alone could be responsible for the pathology, we passively administered R4A or control IgG2b to nonimmunized gestating dams on E12 and examined 
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fetal brains on E15. All preparations contained o100 pg endotoxin which, by itself, caused no histopathology. R4A bound DWEYS and DNA, whereas control IgG2b did not ( Fig. 2a ). R4A-exposed brains showed more apoptotic cells (data not shown), more mitotic cells (Fig. 2b,c) and a thinned cortical plate ( Fig. 2d,e ) compared to brains exposed to isotype control antibody. To confirm that R4A-mediated damage was related to antigenic specificity, we treated pregnant dams with soluble D-peptide (DWEYSVWLSN), nonblocking D-peptide (NEMQSSRLRE) or saline during R4A administration and every 24 h thereafter. Fetal brains from dams given DWEYSVWLSN were normal, whereas fetal brains given NEMQSSRLRE or saline showed a thinned cortical plate ( Supplementary Fig. 4 online). We also administered human monoclonal antibodies derived from B cells of humans with SLE to gestating dams 22 . In utero exposure to the G11 antibody, which is cross-reactive with DNA and NMDAR ( Fig. 3a) , resulted in thinned cortical plate ( Fig. 3b-d ). Exposure to control antibodies (B1 antibody, binding neither DNA nor NMDAR, and D9 antibody, binding DNA but not NMDAR) produced no histopathology ( Fig. 3 and Supplementary Fig. 4 ). Thus, both mouse and human NMDAR-specific autoantibodies were sufficient by themselves to interfere with normal fetal brain development, and neurotoxicity was unrelated to DNA binding.
To assess a functional consequence of autoantibody exposure, we examined the negative geotaxis reflex, which we could quantify reliably in very young pups 23, 24 . MPH mice from dams with high NMDAR-specific autoantibody titers were exposed to approximately tenfold higher titers of NMDARspecific autoantibodies in utero than MPL mice from dams with low autoantibody titers ( Fig. 1a) . MPH pups were delayed in reflex performance (Fig. 4a ). By P16, MC pups performed at adult level, MPL pups were somewhat sluggish and MPH pups were significantly delayed (Fig. 4a ). Late emergence of negative geotaxis correlated with the levels of maternal NMDAR-specific autoantibodies to which the pups were exposed. Notably, delayed acquisition of neonatal reflexes can presage cognitive abnormalities in adults 25 .
Because NMDAR-specific autoantibodies disrupted neocortical development, we decided to test adult offspring in behavioral tasks that depended on proper neocortical processing. We used a fear extinction task 26 , subserved by the infralimbic and prelimbic areas of the prefrontal cortex, to measure behavioral flexibility. Initially, mice received five aversive foot shocks that were paired with a tone (conditional stimulus). All mice readily learned to associate the conditional stimulus with the foot shock, as measured by their increased freezing response ( Supplementary  Fig. 5d online) . Fear extinction was tested 24 h later. MPH mice continued to freeze during conditional stimulus-alone presentations, whereas MC and MPL mice did not freeze by the end of treatment (Fig. 4b , mean percentage freezing on trial 20 ± s.e.m.: MPH, 30.8 ± 4; MPL, 1.9 ± 0.4; MC, 1.6 ± 0.3; n ¼ 8-10, P ¼ 0.0001 for MPH versus MC, by Mann-Whitney U-test). A novel object recognition task 27 , depending specifically on the perirhinal cortex, measured the preference of mice for new objects 27 . MPH mice failed to explore novel objects preferentially (Fig. 4c , mean discrimination ratios ± s.e.m.: MPH, 0.04 ± 0.05; MPL, 0.31 ± 0.07; MC, 0.26 ± 0.06; n ¼ 8-10, P ¼ 0.001 for MPH versus MC, by Mann-Whitney U-test). We used a topological task 28 , depending specifically on the parietal cortex, to assess the spontaneous exploration of transposed items. MPH mice did not show a preference for novel configurations, whereas MC and MPL mice behaved normally (Fig. 4d , mean topological ratios ± s.e.m.: MPH, 0.16 ± 0.07; MPL, 0.4 ± 0.09; MC, 0.5 ± 0.09; n ¼ 8-10, P ¼ 0.015 for MPH versus MC, by Mann-Whitney U-test). Thus, MPH mice had substantially altered neocortically based behaviors. MPL mice, despite an initial lag in reflex acquisition, showed no long-term cognitive or behavioral sequelae. A neurological screen 23 revealed no differences among all groups ( Supplementary Table 1 online) . Additionally, all groups performed comparably on tasks that depended on the integrity of hippocampus, amygdala and striatum ( Supplementary  Fig. 5 ). Adult MPH mice showed disorganization of the neocortical architecture (Fig. 4e) . MPH brains showed significant decreases in neocortical neuron size ( Fig. 4f ) and significant volume decreases in the neocortex (Fig. 4g ). There were no detectable histological abnormalities and volume differences in the hippocampus and the amygdala in MPH mice ( Supplementary Fig. 6 online) .
Our study has clearly established that maternal antibodies are transferred to the fetus during pregnancy and that NMDAR-specific autoantibodies cause congenital brain injuries in a dose-dependent manner, resulting in long-term cognitive deficits. Fetal brain abnormalities translate into delayed neonatal reflex acquisition and impaired performance of neocortical-dependent tasks in adult offspring. Given that the BBB is not fully formed in utero, we show that pathogenic autoantibodies in maternal circulation represent a risk factor for the developing brain, even in the absence of brain disease in the mother.
The enhanced neocortical apoptosis of fetuses from dams harboring high titers of NMDAR-specific autoantibodies during gestation suggests that maternal autoantibodies elicit NMDAR-mediated death of fetal neurons. Although it is possible that maternal autoantibodies destroy fetal glial cells (NMDARs are expressed in astrocytes and oligodendrocytes 29, 30 ), we previously showed that NMDAR-specific autoantibodies do not trigger glial apoptosis 6 . Moreover, because neurogenesis precedes gliogenesis in brain development, it seems likely that fetal pathology, observed as early as E15, is mediated primarily by neuronal NMDARs. NMDAR-specific autoantibodies disrupt the developmental program of the neocortex, as evidenced by the failure to form a normal cortical plate and the increase in mitotic cells distant from the ventricular zone in affected fetuses. NMDARs help govern neuronal migration in the developing brain 31 . It is plausible, therefore, that the cortical abnormalities are related to altered migration of precursor neocortical neurons.
In this model, NMDAR-specific autoantibodies in gestating dams cross-react with the NR2A and NR2B subunits of the NMDAR. We think the observed phenotype in the fetal neocortex could be due to maternal autoantibodies targeting NR2B-containing NMDARs, as NR2B is the predominant NR2 subunit in the mouse fetal cortex 32 . Unlike mouse NR2A expression, which appears to be strictly postnatal, expression of the human NR2A subunit has been detected in the fetal neocortex 33 . This, as well as potential differences in the NMDARassociated signaling cascades, may be a key distinction for understanding species-specific responses to NMDAR-specific autoantibodies.
Previous reports of neurodevelopmental disorders with prenatal origin have implicated a role for maternal serum factors 34, 35 . Mice exposed in utero to human serum from a mother with an autistic child and a language-impaired child showed abnormal exploratory behavior and cerebellar dysfunction 35 . Although this result suggested that maternally derived antibodies could influence behavioral outcomes in offspring, the serum had no definitive neurotoxic properties and was obtained several years after the children's births. Another study shows that IgG purified from serum of mothers with an autistic child, when transferred to pregnant monkeys, caused stereotypies in the offspring akin to those exhibited by autistic children 36 .
Our study suggests that it would be quite informative to examine whether NMDAR-specific autoantibodies are associated with learning disorders in children born from mothers with lupus. It is particularly noteworthy that histological studies of brains from individuals with learning disorders have shown smaller-sized neurons in the neocortex and potential migration defects 37, 38 , both of which are present in our model. Most notably, this study suggests a powerful approach for examining how brain injury mediated by maternal autoantibodies might underlie multiple congenital, neurodevelopmental disorders. The model suggests that other autoantibodies from women with or without lupus could be explored for potential neurotoxic effects on the fetal brain.
METHODS
Mice and immunization. We obtained BALB/c female mice (6-8 weeks old) from Jackson Laboratory. Mouse use was approved by the Institutional Animal Care and Use Committees of Weill Cornell Medical College and the Feinstein Institute for Medical Research. We immunized the mice with multiantigenic peptide coupled to DWEYSVWLSN (MP, 100 mg), control polylysine core (MC, 100 mg), scrambled WSDYEVWLSN (MS, 100 mg), or AAAAAVWLSN (MA, 100 mg, AnaSpec) as previously described 15 . We performed ELISAs for antibody reactivity as previously described 15 . We used mouse monoclonal autoantibody R4A or control IgG2b (200 mg, Southern Biotech), human monoclonal autoantibody G11, human control autoantibody B1 or human DNA-specific antibody D9 (150 mg), obtained by isolating peptide-reactive or nonreactive B cells and expressing the immunoglobulin heavy and light chain genes in 293 cells 39, 40 . We intravenously administered the antibodies to gestating dams at E12. We gave the D form of DWEYSVWLSN peptide (200 mg) or the irrelevant peptide NEMQSSRLRE intraperitoneally to mice at the time of intravenous R4A administration and again 24 h and 48 h later. We intravenously administered europium-labeled monoclonal antibodies (Perkin Elmer; 100 mg) to gestating dams at E14. We stained fetal brains exposed to europium-R4A with antibody to CD31 to identify blood vessels.
Immunohistology of fetal brains. For TUNEL assays, we processed coronal sections (20 mm thick) of E15 brains according to the manufacturer's instructions (R&D Systems) and counterstained them with methyl green. For PH3 assays of mitotic cells, we blocked frozen brain sections (20 mm) with 10% normal goat serum and incubated them overnight at 4 1C with PH3 antibody (1 in 1,000; Chemicon, Millipore) followed by Red X goat antibody to rabbit IgG (Jackson ImmunoResearch Laboratories). We measured the cortical plate and the cerebral width on nestin-(1 in 200; Chemicon) and DAPI-(1 in 1,000; Invitrogen) stained E15 coronal sections with OpenLab software (Improvision, PerkinElmer). We quantified PH3 + and TUNEL + cells with automated image analysis programs on an Axio-Image microscope (Zeiss). We identified anatomical regions using within-section coordinates and counted positive cells in comparable areas of interest.
Behavioral assessment. We measured negative geotaxis 23 in offspring born from MPH (n ¼ 19), MPL (n ¼ 14) and MC (n ¼ 15) dams at P11, P15 or P16 and P20. We placed the mice with their heads facing downward on an incline (451) and measured the time to turn 1801 and climb the incline (maximum 30 s; if the mouse did not reach the top of the incline in the allotted time, we assigned a time of 30 s). We gave each mouse three trials and calculated the mean latency. Adult male offspring from MPH (n ¼ 10), MPL (n ¼ 8) and MC (n ¼ 10) groups underwent a behavioral battery 15, 16 (described in Supplementary Fig. 5 ). We used a blinded format and randomized the order in which the cohorts of mice were tested in different tasks. Tasks that depend on the integrity of neocortical regions are described below. The novel object recognition task 27 consisted of three phases. In the first (sample), mice explored two identical objects for 5 min. In the second (delay), mice stayed in their home cage for 10 min. We replaced the test objects with sample objects, so that one was identical to those in the sample phase (familiar object) and the other was different (novel object). For the final phase (choice), mice inspected the test objects for 5 min. We scored object exploration automatically with AnyMaze software (Stoelting). We defined A3 as the exploration time for the familiar object and B1 as the exploration time for the novel object and measured the discrimination ratio, (B1 -A3) / (B1 + A3). The topological task 28 consisted of five sessions (5 min) with varying intersession intervals (3 min, 10 min, 3 min and 10 min; sequentially). We arranged four different objects in a square. In sessions 1 and 2, we familiarized the mice to this arrangement. Before session 3, we transposed two objects, creating a novel configuration 2. We expected the mice to explore displaced objects more avidly during sessions 3 and 4. Before session 5, we switched the two objects that had remained unchanged, thus creating configuration 3. Session 5 permitted exploration of another novel arrangement. We scored object exploration automatically with AnyMaze. We defined D1 as the sum of the times exploring the displaced objects in configurations 2 and 3 (sessions 3 and 5) and D2 as the sum of the times exploring the nondisplaced objects (sessions 3 and 5). We measured topological processing with the ratio (D1 -D2) / (D1 + D2). The fear extinction task 26 initially required the mice to associate the conditioned stimulus (20-s tone, 5 kHz, 80 dB) with the unconditioned stimulus (foot shock, 1 s, 0.6 mA), as previously described 16 . We tested extinction learning 24 h later by exposing mice to 20 trials of conditional stimulus alone in a novel chamber, with an intertrial interval of 120 s. To determine fear extinction, we measured the amount of freezing during each tone with FreezeFrame software (Actimetrics).
Adult histology. Eight months after birth, we killed and perfused mice that had been subjected to behavioral studies. We used the anterior striatum and the anterior and posterior commissure as internal landmarks to block and section the tissue in order to determine the volume of neocortical areas, hippocampus and amygdala. We stained tissue with cresyl violet and mouse antibody to neuron-specific nuclear protein (NeuN, 1 in 1,000; Chemicon). We sampled coronal sections every fourth 40-mm slice. The internal cortical coordinates were the interhemispheric fissure and the anterior corpus callosum; for hippocampus and amygdala (basolateral and lateral nuclei), we captured the coronal perimeters on video screen by Ibas software (Zeiss) from the dorsal third ventricle to the posterior commissure. For neuron size determinations, we captured video of neurons with an optical dissector, randomly sampling each region of interest.
Statistical analyses. We made statistical comparisons with Kruskal-Wallis and Fisher's analysis of variance, Student's t-test (unpaired, two-sided), the Mann-Whitney U-test and the Kolmogorov-Smirnov nonparametric test. We used the software packages SPSS (SPSS Inc.), Statistica (StatSoft) and Origin (Origi-nLab) for our analyses. P o 0.05 was determined as significant.
Note: Supplementary information is available on the Nature Medicine website.
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